Renal function in patients with anemia and severe chronic heart failure: effects of iron medications

Aim. To investigate the prevalence of anemia and renal dysfunction combination among patients with severe chronic heart failure (CHF), as well as the effects of intravenous (i/v) iron therapy.Material and methods. In total, 42 patients (mean age 69,3+1,2 years) with Functional Class III-IV stable CH...

Full description

Bibliographic Details
Main Authors: M. A. Efremovtseva, T. A. Kasantseva, L. G. Aleksandriya, T. B. Dmitrova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1556
_version_ 1797882744315838464
author M. A. Efremovtseva
T. A. Kasantseva
L. G. Aleksandriya
T. B. Dmitrova
author_facet M. A. Efremovtseva
T. A. Kasantseva
L. G. Aleksandriya
T. B. Dmitrova
author_sort M. A. Efremovtseva
collection DOAJ
description Aim. To investigate the prevalence of anemia and renal dysfunction combination among patients with severe chronic heart failure (CHF), as well as the effects of intravenous (i/v) iron therapy.Material and methods. In total, 42 patients (mean age 69,3+1,2 years) with Functional Class III-IV stable CHF (NYHA classification) were examined. Glomerular filtration rate (GFR) was calculated based on creatinine concentration (MDRD formula). Anemia was diagnosed by WHO criteria: hemoglobin (Hb) level <130 g/1 in men and <120 g/1 in women. Eleven patients were administered Venofer for 24 weeks. At baseline and after the treatment course, 6-minute walk test (6mw) was performed.Results. Anemia was diagnosed in 17 (40,5%) patients, including 13 with iron deficiency. Chronic renal failure (CRF; GFR< 60 ml/min) was observed in 64,7 % of the participants. Clinical and laboratory parameters were compared in patients with cardiorenal syndrome (GFR<60 ml/min) with or without anemia. Significant negative correlation was observed between Hb and creatinine levels (p=-0,02), with positive correlation between hematocrit (Ht) and GFR levels (p=0,044). Intravenous iron therapy was associated with a significant increase in Hb (from 128,2+14,4 to 139,0+17,4 g/1; p=0,03), Ht (from 38,4+3,5 to 41,3+5,06; p=0,03), and physical stress tolerance (PST), according to 6mw test results.Conclusion. The combination of cardiac pathology, renal dysfunction and iron-deficient anemia was typical of patients with severe CHF. Iron therapy was associated with significant increase in Hb, Ht, and PST levels, without any severe adverse effects.
first_indexed 2024-04-10T03:39:31Z
format Article
id doaj.art-722fdb9d83944826b39b247405c85ed6
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:39:31Z
publishDate 2008-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-722fdb9d83944826b39b247405c85ed62023-03-13T07:23:15Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-08-017468711273Renal function in patients with anemia and severe chronic heart failure: effects of iron medicationsM. A. Efremovtseva0T. A. Kasantseva1L. G. Aleksandriya2T. B. Dmitrova3Российский университет дружбы народов, г. МоскваРоссийский университет дружбы народов, г. МоскваРоссийский университет дружбы народов, г. МоскваРоссийский университет дружбы народов, г. МоскваAim. To investigate the prevalence of anemia and renal dysfunction combination among patients with severe chronic heart failure (CHF), as well as the effects of intravenous (i/v) iron therapy.Material and methods. In total, 42 patients (mean age 69,3+1,2 years) with Functional Class III-IV stable CHF (NYHA classification) were examined. Glomerular filtration rate (GFR) was calculated based on creatinine concentration (MDRD formula). Anemia was diagnosed by WHO criteria: hemoglobin (Hb) level <130 g/1 in men and <120 g/1 in women. Eleven patients were administered Venofer for 24 weeks. At baseline and after the treatment course, 6-minute walk test (6mw) was performed.Results. Anemia was diagnosed in 17 (40,5%) patients, including 13 with iron deficiency. Chronic renal failure (CRF; GFR< 60 ml/min) was observed in 64,7 % of the participants. Clinical and laboratory parameters were compared in patients with cardiorenal syndrome (GFR<60 ml/min) with or without anemia. Significant negative correlation was observed between Hb and creatinine levels (p=-0,02), with positive correlation between hematocrit (Ht) and GFR levels (p=0,044). Intravenous iron therapy was associated with a significant increase in Hb (from 128,2+14,4 to 139,0+17,4 g/1; p=0,03), Ht (from 38,4+3,5 to 41,3+5,06; p=0,03), and physical stress tolerance (PST), according to 6mw test results.Conclusion. The combination of cardiac pathology, renal dysfunction and iron-deficient anemia was typical of patients with severe CHF. Iron therapy was associated with significant increase in Hb, Ht, and PST levels, without any severe adverse effects.https://cardiovascular.elpub.ru/jour/article/view/1556хроническая сердечная недостаточностьпочечная дисфункцияжелезодефицитная анемия
spellingShingle M. A. Efremovtseva
T. A. Kasantseva
L. G. Aleksandriya
T. B. Dmitrova
Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
Кардиоваскулярная терапия и профилактика
хроническая сердечная недостаточность
почечная дисфункция
железодефицитная анемия
title Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
title_full Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
title_fullStr Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
title_full_unstemmed Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
title_short Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
title_sort renal function in patients with anemia and severe chronic heart failure effects of iron medications
topic хроническая сердечная недостаточность
почечная дисфункция
железодефицитная анемия
url https://cardiovascular.elpub.ru/jour/article/view/1556
work_keys_str_mv AT maefremovtseva renalfunctioninpatientswithanemiaandseverechronicheartfailureeffectsofironmedications
AT takasantseva renalfunctioninpatientswithanemiaandseverechronicheartfailureeffectsofironmedications
AT lgaleksandriya renalfunctioninpatientswithanemiaandseverechronicheartfailureeffectsofironmedications
AT tbdmitrova renalfunctioninpatientswithanemiaandseverechronicheartfailureeffectsofironmedications